ConductScience.org, home

Paper9728335

Glycosphingolipid degradation and animal models of GM2-gangliosidoses.

Kolter T and 1 other. J Inherit Metab Dis, 1998. Cited by 36 papers, by iCite.

Cite this record

ConductScience Library. Glycosphingolipid degradation and animal models of GM2-gangliosidoses. Papers, record 9728335. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9728335

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Glycosphingolipid degradation and animal models of GM2-gangliosidoses.
PubMed
Journal
J Inherit Metab Dis
PubMed
Year
1998
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
36
iCite
Relative citation ratio, by iCite
0.9
iCite
Revised in PubMed
2026-10-16
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kolter TT
2Sandhoff KK

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GlycosphingolipidsMajor topic
Sandhoff DiseaseMajor topic
Tay-Sachs DiseaseMajor topic
Animals
Disease Models, Animal
Humans
Mice
Mice, Mutant Strains

Source PubMed

Download CSV of topics

References52

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18776585Targeted disruption of the mouse sphingolipid activator protein gene: a complex phenotype, including severe leukodystrophy and wide-spread storage of multiple sphingolipids.Hum Mol Genet1996https://conductscience.org/library/papers/8776585PubMed
22209618The complete amino-acid sequences of human ganglioside GM2 activator protein and cerebroside sulfate activator protein.Eur J Biochem1990https://conductscience.org/library/papers/2209618PubMed
31616002Gangliosides as modulators of cell function.Am J Physiol1992https://conductscience.org/library/papers/1616002PubMed
42673013Animal glycosphingolipids as membrane attachment sites for bacteria.Annu Rev Biochem1989https://conductscience.org/library/papers/2673013PubMed
57550345Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism.Nat Genet1995https://conductscience.org/library/papers/7550345PubMed
62964276The mannose 6-phosphate receptor and the biogenesis of lysosomes.Cell1988https://conductscience.org/library/papers/2964276PubMed
72514102Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: biochemical signs of combined sphingolipidoses.Eur J Pediatr1989https://conductscience.org/library/papers/2514102PubMed
89063740Generalized CNS disease and massive GM1-ganglioside accumulation in mice defective in lysosomal acid beta-galactosidase.Hum Mol Genet1997https://conductscience.org/library/papers/9063740PubMed
93360793Characterization of a nonspecific activator protein for the enzymatic hydrolysis of glycolipids.J Biol Chem1988https://conductscience.org/library/papers/3360793PubMed
1015157485Topology of glycosphingolipid degradation.Trends Cell Biol1996https://conductscience.org/library/papers/15157485PubMed
117590240Mouse model for the lysosomal disorder galactosialidosis and correction of the phenotype with overexpressing erythroid precursor cells.Genes Dev1995https://conductscience.org/library/papers/7590240PubMed
125829234[A cerebrosidesulfatase from swine kidney].Hoppe Seylers Z Physiol Chem1964https://conductscience.org/library/papers/5829234PubMed
137929454N-butyldeoxygalactonojirimycin inhibits glycolipid biosynthesis but does not affect N-linked oligosaccharide processing.J Biol Chem1994https://conductscience.org/library/papers/7929454PubMed
149071485Neurological manifestations of knockout mice with beta-galactosidase deficiency.Brain Dev1997https://conductscience.org/library/papers/9071485PubMed
153024666Immunochemical characterization of two activator proteins stimulating enzymic sphingomyelin degradation in vitro. Absence of one of them in a human Gaucher disease variant.Biol Chem Hoppe Seyler1986https://conductscience.org/library/papers/3024666PubMed
166421563Partial enzyme deficiencies: residual activities and the development of neurological disorders.Dev Neurosci1983https://conductscience.org/library/papers/6421563PubMed
171594045Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene.Nature1992https://conductscience.org/library/papers/1594045PubMed
182060627Mutation in the sphingolipid activator protein 2 in a patient with a variant of Gaucher disease.FEBS Lett1991https://conductscience.org/library/papers/2060627PubMed
19824017Distortion of neuronal geometry and formation of aberrant synapses in neuronal storage disease.Brain Res1976https://conductscience.org/library/papers/824017PubMed
201822229Glycosphingolipids in cell surface recognition.Glycobiology1991https://conductscience.org/library/papers/1822229PubMed

See all 52 referencesDownload CSV of references

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.

PMIDTitleJournalYearIn PapersSource
40916664Generation of mice with combined Hexa Gly269Ser KI or KO and Neu3 KO alleles to create new models of GM2 gangliosidoses.Biol Open2025https://conductscience.org/library/papers/40916664PubMed
40485743DANGO: An MS data annotation tool for glycolipidomics.BBA Adv2025https://conductscience.org/library/papers/40485743PubMed
39190143A multiplexed targeted method for profiling of serum gangliosides and glycosphingolipids: application to GM2-gangliosidosis.Anal Bioanal Chem2024https://conductscience.org/library/papers/39190143PubMed
38098938Characterization of a phenotypically severe animal model for human AB-Variant GM2 gangliosidosis.Front Mol Neurosci2023https://conductscience.org/library/papers/38098938PubMed
37834060Efficacy of Adeno-Associated Virus Serotype 9-Mediated Gene Therapy for AB-Variant GM2 Gangliosidosis.Int J Mol Sci2023https://conductscience.org/library/papers/37834060PubMed
37298170Biochemical Correction of GM2 Ganglioside Accumulation in AB-Variant GM2 Gangliosidosis.Int J Mol Sci2023https://conductscience.org/library/papers/37298170PubMed
33941173Sphingolipid lysosomal storage diseases: from bench to bedside.Lipids Health Dis2021https://conductscience.org/library/papers/33941173PubMed
27499644Animal models of GM2 gangliosidosis: utility and limitations.Appl Clin Genet2016https://conductscience.org/library/papers/27499644PubMed
26329332Large animal models of rare genetic disorders: sheep as phenotypically relevant models of human genetic disease.Orphanet J Rare Dis2015https://conductscience.org/library/papers/26329332PubMed
22496568Lysosomal dysfunction in a mouse model of Sandhoff disease leads to accumulation of ganglioside-bound amyloid-β peptide.J Neurosci2012https://conductscience.org/library/papers/22496568PubMed
22407243Single cell ganglioside catabolism in primary cerebellar neurons and glia.Neurochem Res2012https://conductscience.org/library/papers/22407243PubMed
22038288Invertebrate models of lysosomal storage disease: what have we learned so far?Invert Neurosci2011https://conductscience.org/library/papers/22038288PubMed
19689113Sequential proteolysis and high-field FTICR MS to determine disulfide connectivity and 4-maleimide TEMPO spin-label location in L126C GM2 activator protein.Anal Chem2009https://conductscience.org/library/papers/19689113PubMed
17728461Increasing sulfatide synthesis in myelin-forming cells of arylsulfatase A-deficient mice causes demyelination and neurological symptoms reminiscent of human metachromatic leukodystrophy.J Neurosci2007https://conductscience.org/library/papers/17728461PubMed
14605503Towards quality assurance in the determination of lysosomal enzymes: a two-centre study.J Inherit Metab Dis2003https://conductscience.org/library/papers/14605503PubMed
11904372The Caenorhabditis elegans mucolipin-like gene cup-5 is essential for viability and regulates lysosomes in multiple cell types.Proc Natl Acad Sci U S A2002https://conductscience.org/library/papers/11904372PubMed
11407166Ptosis in late infantile Tay-Sachs disease.Indian J Pediatr2001https://conductscience.org/library/papers/11407166PubMed
9728328Sphingolipids and cell signalling.J Inherit Metab Dis1998https://conductscience.org/library/papers/9728328PubMed
9458169Recent advances in the biochemistry of sphingolipidoses.Brain Pathol1998https://conductscience.org/library/papers/9458169PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9728335

GET https://conductscience.org/api/papers/v1/9728335/references?page=2